2 yrs - Translate

Global Influenza Medication Market | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Transrectal Ultrasound Industry, published by Fortune Business Insights. According to this report Global Influenza Medication Market to rise at healthy Compound Annual Growth Rate By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Click here to know more:

https://www.fortunebusinessins....ights.com/industry-r

Major Influenza Medication Manufacturers covered in the market report include:

Alvogen
Amneal Pharmaceuticals LLC
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Seqirus (CSL)
Genentech, Inc.
Macleods Pharmaceuticals Ltd.
Zydus Pharmaceuticals, Inc. (Zydus Cadila)
Lupin Limited
BIOCRYST PHARMACEUTICALS, INC.
Shionogi & Co., Ltd.
Get Sample PDF Brochure Of Influenza Medication Market Report at:

https://www.fortunebusinessins....ights.com/enquiry/sa

Rising Threat from Risk Factors for Influenza to Propel the Market

Prominent among the influenza medication market trends is the threats posed by the risk factors inducing or worsening the effects of influenza infection in humans. According to the CDC, the people most at risk for flu complications include pregnant women, diabetics, asthmatics, adults aged 65 or older, young children, HIV/AIDS patients, cancer patients, and people suffering from chronic lung or heart condition.

For example, congestive heart condition in a person can worsen if she contracts the flu infection. The influenza drugs market growth is further bolstered by the rising prevalence of these risk factors. For instance, the WHO estimates that approximately 235 million people worldwide are living with asthma currently, while 18.1 million new cancer cases were reported worldwide in 2018, the WHO states.

Influenza Medication Market Size, Share | Forecast [2019-2026]
www.fortunebusinessinsights.com

Influenza Medication Market Size, Share | Forecast [2019-2026]

The global influenza medication market size stood at USD 889.2 million in 2018 and is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period.